Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
3 ways the pros are trading markets right now, including a Goldman strategist on what’s next for Kospi
U.S. futures unchanged amid Iran talks as strategists highlight emerging markets, Korea stocks and non-AI plays in the U.K.
OpenAI to give EU access to new cyber model but Anthropic still holding out on Mythos
OpenAI announced on Thursday it was granting preview access to its latest cyber model to vetted cybersecurity teams.
Nintendo plunges 8% after Switch 2 price hike and weak sales forecast
Investors are concerned about Nintendo’s outlook of lower Switch 2 sales in the current fiscal year, driven by price increases for the console.
UK PM Starmer battles for political survival amid leadership challenge as gilt yields rise
Starmer said that key issues of growth, defense, the U.K.’s relationship with Europe and energy must be urgently addressed.
Treasury yields move higher as Middle East peace talks falter
Treasury yields rose Monday as traders reacted to the latest developments in the Middle East conflict.
JPMorgan thinks Kospi’s torrid AI rally could have another 25% or more to run
JPMorgan sees South Korea’s Kospi index climbing another 25%, on top of an incredible rally of more than 80% already this year.
JPMorgan thinks Kospi’s torrid AI rally could have another 25% or more to run
JPMorgan sees South Korea’s Kospi index climbing another 25%, on top of an incredible rally of more than 80% already this year.
CNBC Daily Open: Political pressure cooker week
Markets eye three high-stakes political stories this week, with the U.S., Iran, China and the U.K. front and center.
European markets mixed as Iran’s peace talks stall, defense stocks slide
European stocks were largely mixed in Monday trade as investors digest the latest in U.S.-Iran peace negotiations.
